Radioimaging Foam Cells Infiltrating Atherosclerotic Plaques in Mice Using 125I-labeled oxLDL as a Radiotracer

IF 3 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Michi Izawa, Hidekazu Kawashima, Yui Okuno, Junna Nakaya, Mayuko Takeda, Koki Harada, Yuri Yamada, Kaneyasu Nishimura, Keiichi Ishihara, Satoshi Akiba, Kazuyuki Takata
{"title":"Radioimaging Foam Cells Infiltrating Atherosclerotic Plaques in Mice Using 125I-labeled oxLDL as a Radiotracer","authors":"Michi Izawa, Hidekazu Kawashima, Yui Okuno, Junna Nakaya, Mayuko Takeda, Koki Harada, Yuri Yamada, Kaneyasu Nishimura, Keiichi Ishihara, Satoshi Akiba, Kazuyuki Takata","doi":"10.1007/s11307-024-01951-9","DOIUrl":null,"url":null,"abstract":"<p>Bioimaging such as magnetic resonance is used to monitor atherosclerotic plaques consisting of foam cells, which are derived from macrophages that have ingested oxidized low-density lipoprotein (oxLDL). However, the current bioimaging techniques are not highly specific and sensitive in detecting foam cells, calling for the development of higher precision foam cell detection probes. Here, we investigated the utility of iodine-125-labeled oxLDL (<sup>125</sup>I-oxLDL) as a prototype radiotracer in the radioimaging of foam cells infiltrating atherosclerotic plaques. Mouse bone marrow-derived macrophages (BMDMs) were used to analyze oxLDL uptake. Atherosclerosis mouse model was injected with <sup>125</sup>I-oxLDL and DiI-labeled oxLDL (DiI-oxLDL). Accumulation of <sup>125</sup>I-oxLDL and DiI-oxLDL in foam cells infiltrating atherosclerotic plaques was examined using Oil Red O (ORO) staining, autoradiography, and fluorescent immunohistochemistry. BMDMs phagocytosed oxLDL/<sup>125</sup>I-oxLDL via CD36, but not LDL/<sup>125</sup>I-LDL. The radioactive signal from <sup>125</sup>I-oxLDL phagocytosed by the BMDMs could be detected for at least 3 days. In atherosclerosis mouse model, atherosclerotic plaques formed in the aortic arches and valves. The radioactive signal of the injected <sup>125</sup>I-oxLDL was detected in atherosclerotic plaques of the aortic arch, and its intensity was positively correlated with the lesion size. Furthermore, the DiI-oxLDL fluorescent signals were detected in foam cells accumulating in atherosclerotic plaques. Thus, we found that <sup>125</sup>I-oxLDL can be used as a radiotracer in the radioimaging of foam cells in atherosclerotic plaques by autoradiography, suggesting its potential future applications in bioimaging methods such as single-photon emission computed tomography.</p>","PeriodicalId":18760,"journal":{"name":"Molecular Imaging and Biology","volume":"45 1","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Imaging and Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11307-024-01951-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Bioimaging such as magnetic resonance is used to monitor atherosclerotic plaques consisting of foam cells, which are derived from macrophages that have ingested oxidized low-density lipoprotein (oxLDL). However, the current bioimaging techniques are not highly specific and sensitive in detecting foam cells, calling for the development of higher precision foam cell detection probes. Here, we investigated the utility of iodine-125-labeled oxLDL (125I-oxLDL) as a prototype radiotracer in the radioimaging of foam cells infiltrating atherosclerotic plaques. Mouse bone marrow-derived macrophages (BMDMs) were used to analyze oxLDL uptake. Atherosclerosis mouse model was injected with 125I-oxLDL and DiI-labeled oxLDL (DiI-oxLDL). Accumulation of 125I-oxLDL and DiI-oxLDL in foam cells infiltrating atherosclerotic plaques was examined using Oil Red O (ORO) staining, autoradiography, and fluorescent immunohistochemistry. BMDMs phagocytosed oxLDL/125I-oxLDL via CD36, but not LDL/125I-LDL. The radioactive signal from 125I-oxLDL phagocytosed by the BMDMs could be detected for at least 3 days. In atherosclerosis mouse model, atherosclerotic plaques formed in the aortic arches and valves. The radioactive signal of the injected 125I-oxLDL was detected in atherosclerotic plaques of the aortic arch, and its intensity was positively correlated with the lesion size. Furthermore, the DiI-oxLDL fluorescent signals were detected in foam cells accumulating in atherosclerotic plaques. Thus, we found that 125I-oxLDL can be used as a radiotracer in the radioimaging of foam cells in atherosclerotic plaques by autoradiography, suggesting its potential future applications in bioimaging methods such as single-photon emission computed tomography.

Abstract Image

使用 125I 标记的 oxLDL 作为放射性示踪剂,对小鼠动脉粥样硬化斑块中浸润的泡沫细胞进行放射性成像
磁共振等生物成像技术用于监测由泡沫细胞组成的动脉粥样硬化斑块,泡沫细胞来自摄入氧化低密度脂蛋白(oxLDL)的巨噬细胞。然而,目前的生物成像技术在检测泡沫细胞方面的特异性和灵敏度不高,因此需要开发更精确的泡沫细胞检测探针。在此,我们研究了碘-125标记的氧化LDL(125I-oxLDL)作为放射性示踪剂原型在动脉粥样硬化斑块浸润的泡沫细胞放射性成像中的应用。小鼠骨髓衍生巨噬细胞(BMDMs)被用来分析对 oxLDL 的吸收。给动脉粥样硬化小鼠模型注射 125I-oxLDL 和 DiI 标记的 oxLDL(DiI-oxLDL)。使用油红 O(ORO)染色法、自显影法和荧光免疫组化法检测了 125I-oxLDL 和 DiI-oxLDL 在动脉粥样硬化斑块浸润的泡沫细胞中的积累情况。BMDMs通过CD36吞噬oxLDL/125I-oxLDL,但不吞噬LDL/125I-LDL。BMDMs吞噬的125I-oxLDL的放射性信号至少可在3天内被检测到。在动脉粥样硬化小鼠模型中,主动脉弓和瓣膜形成了动脉粥样硬化斑块。在主动脉弓的动脉粥样硬化斑块中检测到了注射的125I-oxLDL的放射性信号,其强度与病变的大小呈正相关。此外,在动脉粥样硬化斑块中积聚的泡沫细胞中也检测到了 DiI-oxLDL 荧光信号。因此,我们发现125I-oxLDL可作为一种放射性示踪剂,通过自显影技术对动脉粥样硬化斑块中的泡沫细胞进行放射性成像,这表明它未来有可能应用于单光子发射计算机断层扫描等生物成像方法中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.90
自引率
3.20%
发文量
95
审稿时长
3 months
期刊介绍: Molecular Imaging and Biology (MIB) invites original contributions (research articles, review articles, commentaries, etc.) on the utilization of molecular imaging (i.e., nuclear imaging, optical imaging, autoradiography and pathology, MRI, MPI, ultrasound imaging, radiomics/genomics etc.) to investigate questions related to biology and health. The objective of MIB is to provide a forum to the discovery of molecular mechanisms of disease through the use of imaging techniques. We aim to investigate the biological nature of disease in patients and establish new molecular imaging diagnostic and therapy procedures. Some areas that are covered are: Preclinical and clinical imaging of macromolecular targets (e.g., genes, receptors, enzymes) involved in significant biological processes. The design, characterization, and study of new molecular imaging probes and contrast agents for the functional interrogation of macromolecular targets. Development and evaluation of imaging systems including instrumentation, image reconstruction algorithms, image analysis, and display. Development of molecular assay approaches leading to quantification of the biological information obtained in molecular imaging. Study of in vivo animal models of disease for the development of new molecular diagnostics and therapeutics. Extension of in vitro and in vivo discoveries using disease models, into well designed clinical research investigations. Clinical molecular imaging involving clinical investigations, clinical trials and medical management or cost-effectiveness studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信